272 related articles for article (PubMed ID: 33241323)
1. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
Zirovich MD; Pangarkar SS; Manh C; Chen L; Vangala S; Elashoff DA; Izuchukwu IS
Mil Med; 2021 May; 186(5-6):493-499. PubMed ID: 33241323
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
Bono F; Mazza MR; Magro G; Spano G; Idone G; Laterza V; Tedeschi D; Pucci F; Gambardella A; Sarica A
Toxins (Basel); 2023 May; 15(5):. PubMed ID: 37235358
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache.
Wang Y; Yang X; Ji X; Liu M; Zhou C
Psychopharmacology (Berl); 2023 Oct; 240(10):2061-2070. PubMed ID: 37481677
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans.
Mayer CL; Savage PJ; Engle CK; Groh SS; Shofer JB; Hargrove AM; Williams TJ; Poupore EL; Hart KL; Riechers RG; Ruff RL; Peskind ER; Raskind MA
Headache; 2023 Jun; 63(6):751-762. PubMed ID: 37313689
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.
Sandrini G; Perrotta A; Tassorelli C; Torelli P; Brighina F; Sances G; Nappi G
J Headache Pain; 2011 Aug; 12(4):427-33. PubMed ID: 21499747
[TBL] [Abstract][Full Text] [Related]
11. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
Nicol AL; Wu II; Ferrante FM
Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
Jackson JL; Kuriyama A; Hayashino Y
JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
Bruloy E; Sinna R; Grolleau JL; Bout-Roumazeilles A; Berard E; Chaput B
Plast Reconstr Surg; 2019 Jan; 143(1):239-250. PubMed ID: 30589800
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
16. Is botulinum toxin A effective for the treatment of plantar fasciitis?
Peterlein CD; Funk JF; Hölscher A; Schuh A; Placzek R
Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
[TBL] [Abstract][Full Text] [Related]
17. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
19. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
Ondo WG; Simmons JH; Shahid MH; Hashem V; Hunter C; Jankovic J
Neurology; 2018 Feb; 90(7):e559-e564. PubMed ID: 29343468
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
Dowson AJ; Kilminster SG; Salt R
Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]